D
Daniel Aletaha
Researcher at Medical University of Vienna
Publications - 398
Citations - 51111
Daniel Aletaha is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 74, co-authored 298 publications receiving 43215 citations. Previous affiliations of Daniel Aletaha include National Institutes of Health & University of Vienna.
Papers
More filters
Journal ArticleDOI
Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative
Samuel L Whittle,Alexandra N. Colebatch,Rachelle Buchbinder,Christopher J Edwards,Karen Adams,Matthias Englbrecht,Glen Hazlewood,Jonathan L. Marks,Helga Radner,Sofia Ramiro,Bethan Richards,Ingo H. Tarner,Daniel Aletaha,Claire Bombardier,Robert Landewé,Ulf Müller-Ladner,Johannes W. J. Bijlsma,Jaime Branco,Vivian P. Bykerk,Geraldo da Rocha Castelar Pinheiro,Anca I. Catrina,Pekka Hannonen,Patrick D W Kiely,Burkhard F. Leeb,Elisabeth Lie,Pindaro Martinez-Osuna,Carlomaurizio Montecucco,Mikkel Østergaard,René Westhovens,Jane Zochling,Désirée van der Heijde +30 more
TL;DR: Eleven evidence-based recommendations on the management of pain by pharmacotherapy in IA were developed and are supported by a large panel of rheumatologists from 17 countries, thus enhancing their utility in clinical practice.
Journal ArticleDOI
Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects.
TL;DR: Therapy of rheumatoid arthritis aims at interfering with the disease process, namely inflammation and destruction of the joints, and thus at preventing long-term disability.
Journal ArticleDOI
Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008
Monika Schoels,Daniel Aletaha,Josef S. Smolen,Johannes W. J. Bijlsma,Gerd R Burmester,Ferdinand C. Breedveld,Maurizio Cutolo,Bernard Combe,Maxime Dougados,Paul Emery,Joachim R. Kalden,Edward C. Keystone,Tore K Kvien,Emilio Martín-Mola,Carlomaurizio Montecucco,Maarten de Wit +15 more
TL;DR: These results suggest the acceptance of ambitious treatment concepts in practice, and reflect widespread adoption of desirable standards of care, in practice.
Journal ArticleDOI
Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity.
TL;DR: The data reveal that damage progression in seropositive RA patients is related to higher levels of disease activity and to independent effects of RF, particularly on bone damage.
Journal ArticleDOI
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey.
Nadia M T Roodenrijs,Maria J. H. de Hair,Marlies C van der Goes,Johannes W G Jacobs,Paco M J Welsing,Désirée van der Heijde,Daniel Aletaha,Maxime Dougados,Kimme L. Hyrich,Iain B. McInnes,Ulf Mueller-Ladner,Ladislav Šenolt,Zoltán Szekanecz,Jacob M van Laar,György Nagy +14 more
TL;DR: There is wide variation in concepts of difficult-to-treat RA.